bpc 157 human case reports adverse effects The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and Safety BPC 157 in Australia: Benefits,

BPC-157 has been shown to: Increase vascular endothelial growth factor receptor 2 (VEGFR2) expression

Alternative Names: Thymosin Beta-4, Synthetic T4 TB-500 Studies and Research Data Proposed Interactions with Actin One area of study centers on how TB-500 may interact with actin proteins, which are critical to maintaining cytoskeletal architecture

The relevance to peptide therapy is this: the endogenous opioid peptides that LDN upregulates, particularly OGF/met-enkephalin, are the actual therapeutic agents

Here it is

Ishiyama N, Moro T, Ishihara K, Ohe T, Miura T, Konno T, et al

Anti-inflammatory & cytoprotective actions (GI and beyond)